Michel Azizi
Latest contributions
IBERIS: the first radial renal denervation (RDN) system for the treatment of uncontrolled hypertension
20 May 2026 – From EuroPCR 2026
This session introduces the IBERIS system, the first radial-access platform for renal denervation in patients with uncontrolled hypertension. It covers patient selection, procedural planning, and key technical considerations for both transfemoral and transradial approaches. A LIVE case demonstration highlights essential procedural steps while addressing the clinical...
Patient selection for renal denervation in 2023
17 May 2023 – From EuroPCR 2023
While many clinical studies have demonstrated the superiority of renal denervation, the question that Felix Mahfoud asks Michel Azizi is when and in which patients to use this technique. Referring to the new consensus guidelines, our hypertension expert provides some answers in this exclusive interview recorded during EuroPCR 2023....
Comeback of renal denervation: The ESC Council on hypertension/EAPCI clinical consensus statement
16 May 2023 – From EuroPCR 2023
Ready to rejuvenate your memory of this session tackling on renal denervation? Investigate these slides and review the take home messages.
EuroPCR 2022 Hotlines / Late-Breaking Trials in hypertension management: SPYRAL-HTN ON MED, radiance HTN SOLO and TRIO, and more!
17 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in hypertension management! Blood pressure and MACE reductions after renal denervation: 3-year GSR results, patient-level pooled analysis of ultrasound RDN in radiance-HTN SOLO and Trio, and SPYRAL-HTN ON MED 3 year data.
